MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland · Delayed Price · Currency is CHF 0.1992
+0.0012 (0.61%)
Jul 31, 2026, 5:30 PM CET
SWX:MMTX Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 4.05 | 8.42 | 6.03 | 6.08 | 3.32 | - | |
Revenue Growth | -52.81% | 39.52% | -0.79% | 83.11% | - | - |
Gross Profit | 4.05 | 8.42 | 6.03 | 6.08 | 3.32 | - |
Selling, General & Admin | 7.91 | 9.83 | 19.43 | 24.05 | 16.24 | 5.63 |
Depreciation & Amortization Expenses | 1.87 | 2.56 | 3.32 | 3.86 | 2.04 | - |
Research & Development | 1.2 | 1.36 | 1.33 | 12.39 | 19.02 | 13.67 |
Other Operating Expenses | 0.07 | 23.14 | 102.35 | 35.6 | 0.33 | 12.19 |
Total Operating Expenses | 11.05 | 36.89 | 126.43 | 75.91 | 37.63 | 31.49 |
Operating Income | -7 | -28.48 | -120.39 | -69.82 | -34.31 | -31.49 |
Interest Income | 0.01 | 0.19 | 0.09 | 0.02 | 0.1 | 0.01 |
Interest Expense | -0.54 | -0.66 | -0.95 | -2.29 | -1.32 | -0.57 |
Other Non-Operating Income (Expense) | - | - | - | - | - | 3.38 |
Total Non-Operating Income (Expense) | -0.53 | -0.47 | -0.86 | -2.28 | -1.22 | 2.82 |
Pretax Income | -19.86 | -19.36 | -111.68 | -54.32 | -35.53 | -6.26 |
Provision for Income Taxes | -2.82 | -2.24 | -13.5 | -3.53 | -0.82 | 1.57 |
Net Income | -17.04 | -17.12 | -98.18 | -50.79 | -34.71 | -7.83 |
Net Income to Common | -17.04 | -17.12 | -98.18 | -50.79 | -34.71 | -7.83 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 13 | 13 | 12 | 11 | 3,593 | 2,413 |
Shares Outstanding (Diluted) | 13 | 13 | 12 | 11 | 3,593 | 2,413 |
Shares Change | 0.52% | 6.71% | 11.18% | -99.71% | 48.89% | 14.70% |
EPS (Basic) | -1.36 | -1.36 | -8.35 | -4.80 | -0.01 | -0.00 |
EPS (Diluted) | -1.36 | -1.36 | -8.35 | -4.80 | -0.01 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -3.54 | -2.93 | -18.06 | -24.16 | -35.72 | -18.25 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.28 | -0.23 | -1.54 | -2.29 | -0.01 | -0.01 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
Operating Margin | -172.59% | -338.30% | -1995.56% | -1148.23% | -1033.00% | - |
Profit Margin | -420.33% | -203.39% | -1627.40% | -835.22% | -1045.02% | - |
FCF Margin | -87.22% | -34.81% | -299.32% | -397.29% | -1075.52% | - |
EBITDA | -5.13 | -25.91 | -117.07 | -65.96 | -32.27 | -31.49 |
EBITDA Margin | -126.47% | -307.88% | -1940.56% | -1084.76% | -971.70% | - |
EBIT | -7 | -28.48 | -120.39 | -69.82 | -34.31 | -31.49 |
EBIT Margin | -172.59% | -338.30% | -1995.56% | -1148.23% | -1033.00% | - |
Effective Tax Rate | 14.21% | 11.56% | 12.09% | 6.49% | 2.31% | -25.03% |